After twice rejecting the drug, the FDA is taking yet another look at flibanserin, the first drug that aims to boost a woman’s libido. Interestingly, some groups have accused the FDA of being sexist by holding the drug to a higher standard than its counterparts — which, for years, men have been swallowing by the bucket-load. (But wouldn’t it be more sexist if the FDA had set aside concerns and approved the drug right away?)